Author

L. Rodgers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

C. A. Ford· 1 shared D. G. Watson· 1 shared D. Sumpton· 1 shared E. Mui· 1 shared G. MacKay· 1 shared H. Y. Leung· 1 shared J. Fleming· 1 shared L. Rushworth· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. A. Ford

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cyclocreatine suppresses prostate tumorigenesis through dual effects on SAM and creatine metabolism

R. Patel, L. Rodgers, C. A. Ford, L. Rushworth, J. Fleming, E. Mui, T. Zhang, D. G. Watson, G. MacKay, D. Sumpton, O. J. Sansom, H. Y. Leung

This study identifies cyclocreatine as a dual-action inhibitor of prostate cancer by blocking the phosphagen system and increasing S-adenosyl methionine levels.

bioRxiv · Feb 26, 2021 · PreprintCancer Biology